Citadel Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $26 | Sell |
|
|||||
|
2024
Q4 | $661K | Buy |
|
|||||
|
2024
Q3 | $37 | Sell |
|
|||||
|
2024
Q2 | $1.24M | Sell |
|
|||||
|
2024
Q1 | $5.56M | Buy |
|
|||||
|
2023
Q4 | $5.34M | Sell |
|
|||||
|
2023
Q3 | $26.3M | Sell |
|
|||||
|
2023
Q2 | $52.2M | Sell |
|
|||||
|
2023
Q1 | $58.5M | Buy |
|
|||||
|
2022
Q4 | $37.4M | Sell |
|
|||||
|
2022
Q3 | $28.6M | Buy |
|
|||||
|
2022
Q2 | $1.4M | Sell |
|
|||||
|
2022
Q1 | $20.5M | Buy |
|
|||||
|
2021
Q4 | $7.25M | Sell |
|
|||||
|
2021
Q3 | $10.3M | Buy |
|
|||||
|
2021
Q2 | $9.32M | Sell |
|
|||||
|
2021
Q1 | $12M | Buy |
|
|||||
|
2020
Q4 | $819K | Sell |
|
|||||
|
2020
Q3 | $3.01M | Buy |
|
|||||
|
2020
Q2 | $592K | Buy |
|
|||||
|
2020
Q1 | $342K | Buy |
|
|||||
|
2019
Q4 | $161K | Buy |
|
|||||
|
2019
Q3 | $97K | Sell |
|
|||||
|
2019
Q2 | $26.7M | Buy |
|
|||||
|
2019
Q1 | $19.1M | Buy |
|
|||||
|
2018
Q4 | $146K | Sell |
|
|||||
|
2018
Q3 | $290K | Sell |
|
|||||
|
2018
Q2 | $2.31M | Buy |
|
|||||
|
2018
Q1 | $967K | Buy |
|
|||||
|
2017
Q4 | $314K | Buy |
|
|||||
|
2017
Q3 | $98K | Sell |
|
|||||
|
2017
Q2 | $185K | Sell |
|
|||||
|
2017
Q1 | $653K | Sell |
|
|||||
|
2016
Q4 | $517K | Sell |
|
|||||
|
2016
Q3 | $17.3M | Buy |
|
|||||
|
2016
Q2 | $3.59M | Buy |
|
|||||
|
2016
Q1 | $1.99M | Buy |
|
|||||
|
2015
Q4 | $2.62M | Buy |
|
|||||
|
2015
Q3 | $160K | Buy |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $327K | Buy |
|
|||||
|
2014
Q3 | $34K | Sell |
|
|||||
|
2014
Q2 | $276K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $130K | Buy |
|